Sage Therapeutics knows it needs to do something. But it doesn’t want to sell to its partner Biogen.
On Monday, the troubled biotech said its …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
MONTREAL – A predictive calculator aims to offer patients with oral cancer a personalized estimate of survival that takes into consideration the effects of co-existing
Digital breast tomosynthesis (DBT) screening supplemented by MRI for women with dense breasts led to both greater benefits and increased harms in a model-based comparative
Share this article The pharmaceutical industry is already highly competitive. It’s a business driven by the compassionate desire to discover and develop therapies to improve